Franklin

Federal R&D, Drug Discovery, and Pricing [electronic resource] : Insights from the NIH-University-Industry Relationship.

Author/Creator:
Library of Congress. Congressional Research Service. Resources, Science, and Industry Division.
Publication:
[S.l] : [s.n.], 2011.
Format/Description:
Government document
Book
1 online resource (32 p., digital, PDF file)
Status/Location:
Loading...

Options
Location Notes Your Loan Policy

Details

Subjects:
Medicine -- Research.
Pharmaceutical industry.
Price regulation.
System Details:
System requirements: PDF reader software.
Summary:
Explores reasons behind Government funding of R&D and subsequent efforts to facilitate private sector commercialization of the results of such work. Examines the manner in which NIH supports research to encourage the development of new pharmaceuticals and therapeutics through cooperative activities with academia, industry, and Government. Discusses whether or not use of the results of Federal R&D enterprise warrants Government input into price decisions made by the private sector. Addresses concerns surrounding innovation in health-related areas within context of Government role in facilitating technological progress.
Notes:
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Jan. 2013). Reuse except for individual research requires license from ProQuest, LLC.
CRS Report.
Other format:
Microfiche version: Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. Federal R&D, Drug Discovery, and Pricing
Access Restriction:
Restricted for use by site license.